• Russ Biagio Altman, M.D., Ph.D.

    Kenneth Fong Professor of Bioengineering, Genetics, Medicine, Biomedical Data Science, and (by courtesy) Computer Science
    Stanford University
  • David W. Bates, M.D., M.Sc.

    Chief
    Division of General Internal Medicine, Brigham and Women’s Hospital
    Medical Director
    Clinical and Quality Analysis for Partners Healthcare
    Professor of Medicine
    Harvard Medical School
    Professor of Health Policy and Management
    Harvard School of Public Health
    Co-Director
    Program in Clinical Effectiveness, Harvard School of Public Health
  • Robert Califf, M.D., MACC

    Vice Chancellor for Health Data Science, Duke University Advisor, Verily Life Sciences
  • Kevin P. Campbell, Ph.D.

    Investigator
    Howard Hughes Medical Institute
    Department Executive Officer
    Molecular Physiology and Biophysics
    Roy J. and Lucille A. Carver Biomedical Research Chair
    Molecular Physiology and Biophysics
    Professor
    Neurology
    Director
    Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers (MDCRC)
  • Thomas R. Cech, Ph.D.

    Distinguished Professor
    University of Colorado-Boulder
    Director
    University of Colorado Biofrontiers Institute
    Investigator
    Howard Hughes Medical Institute
  • Thomas O. Daniel, M.D.

    Founding Executive Director
    Catalysis Advisors
    Former President of Research and Early Development
    Celgene Corporation
  • David Glazer

    Engineering Director
    Verily

     

     

  • Ann Graybiel, Ph.D.

    Institute Professor
    Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology
    Principal Investigator
    McGovern Institute for Brain Research, Massachusetts Institute of Technology
  • William N. Hait, M.D., Ph.D.

    Global Head, Research and Development
    Janssen, Pharmaceutical Companies of Johnson & Johnson
  • William G. Kaelin, Jr., M.D.

    Professor of Medicine
    Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Harvard Medical School
    Investigator
    Howard Hughes Medical Institute
    Associate Director, Basic Science
    Dana-Farber Cancer Institute/Harvard Cancer Center
  • Mark T. Keating, M.D.

    President and CEO
    Cambridge Therapeutics, Cambridge, MA
    Former Vice President and Global Head of Cardiovascular and Metabolic Diseases
    Novartis Institutes for BioMedical Research, Inc.
  • Michael A. Marletta, Ph.D.

    CH and Annie Li Chair in the Molecular Biology of Diseases
    Department of Chemistry
    Department of Molecular and Cell Biology
    University of California, Berkeley
  • Olufunmilayo I Olopade, M.D., F.A.C.P., O.O.N.

    Walter L. Palmer Distinguished Service Professor of Medicine and Human Genetics
    University of Chicago
    Associate Dean of Global Health
    University of Chicago
    Director, Center for Clinical Cancer Genetics
    University of Chicago
  • Neil R. Powe, M.D., M.P.H., M.B.A.

    Constance B. Wofsy Distinguished Professor of Medicine
    Vice-Chairman, Department of Medicine
    University of California San Francisco
    Chief of Medicine
    San Francisco General Hospital
    Professor of Medicine
    University of California San Francisco
  • Susan S. Taylor, Ph.D.

    Distinguished Professor
    Department of Chemistry & Biochemistry, Department of Pharmacology (University of California, San Diego)
  • Michael W. Young, Ph.D.

    Richard and Jeanne Fisher Professor, Head of Laboratory of Genetics and V.P. for Academic Affairs at The Rockefeller University